A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
This is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in adult participants with non-responsive celiac dise...
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
The primary efficacy objective of the trial is to assess the ability of TEV-53408 to attenuate gluten-induced enteropathy in adults with celiac disease. The primary safety objective of the trial is t...
Top Cities for Celiac Disease Clinical Trials
Celiac Disease clinical trials are recruiting across 19 cities. Here are the cities with the most active studies:
About Celiac Disease
Celiac disease is an autoimmune condition triggered by eating gluten, causing damage to the small intestine lining. It affects about 1% of the global population and can cause digestive symptoms, malnutrition, and other complications. The primary treatment is a strict lifelong gluten-free diet.
Clinical trials are advancing new treatments for celiac disease. Currently, 2 studies are recruiting a combined 252 participants across the United States. Research is being conducted by 2 organizations including Sanofi, Teva Branded Pharmaceutical Products R&D LLC.
2026 Celiac Disease Research Landscape
As of March 2026, the celiac disease clinical trial landscape includes 2 actively recruiting studies across 19 cities in the United States. These studies are collectively seeking 252 participants, with an average enrollment target of 126 per study.
Research is being led by 2 different organizations, including Sanofi, Teva Branded Pharmaceutical Products R&D LLC.
Geographically, celiac disease trials are most concentrated in Miami Lakes, Florida (2 trials); Arcadia, California (1 trial); Camarillo, California (1 trial); Lancaster, California (1 trial); Los Alamitos, California (1 trial) and 7 other cities.
Featured Celiac Disease Studies
Highlighted recruiting studies for celiac disease, selected by enrollment size and research scope.
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
This is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in adult participants with non-responsive celiac disease (NRCD) who are on a gluten free diet (GFD) with and without simulated inadvertent gluten exposure (SIGE). The primary purpose of this study is to demonstrate the efficacy of subcutaneous (SC) aml...
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
The primary efficacy objective of the trial is to assess the ability of TEV-53408 to attenuate gluten-induced enteropathy in adults with celiac disease. The primary safety objective of the trial is to assess the safety of TEV-53408 in adults with celiac disease. A secondary objective is to further assess the efficacy of TEV-53408 in adults with celiac disease. The expected trial duration per pa...
Frequently Asked Questions About Celiac Disease Clinical Trials
Are there celiac disease clinical trials near me?
Yes, there are 2 celiac disease clinical trials currently recruiting across 19+ cities in the United States, including Miami Lakes, Florida; Arcadia, California; Camarillo, California. Browse the studies above to find one at a location convenient for you.
How do I join a celiac disease clinical trial?
To join a celiac disease clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are celiac disease clinical trials free?
Yes, participation in celiac disease clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of celiac disease treatments are being studied?
Current celiac disease clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in celiac disease clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov